Viewing Study NCT02621333


Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2026-02-24 @ 9:03 AM
Study NCT ID: NCT02621333
Status: TERMINATED
Last Update Posted: 2021-05-12
First Post: 2015-11-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma
Sponsor: Henan Cancer Hospital
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: HenanCH003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER_GOV View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View